Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
CU-20101 treatment for Moderate to Severe Glabellar Striae Phase 3 Results Expected
CU-20101 treatment for Moderate to Severe Glabellar Striae • Glabellar Frown Lines
Target Indication
Glabellar Frown Lines
Clinical Trial
NCT06585696Last updated: 12/13/2025